Allianz Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.67M | Buy |
12,700
+1,300
| +11% | +$606K | 0.01% | 1105 |
|
|
2025
Q4 | $5.17M | Sell |
11,400
-2,500
| -18% | -$1.08M | 0.01% | 1128 |
|
|
2025
Q3 | $5.44M | Sell |
13,900
-2,900
| -17% | -$1.21M | 0.01% | 1080 |
|
|
2025
Q2 | $7.48M | Buy |
16,800
+3,700
| +28% | +$1.71M | 0.01% | 922 |
|
|
2025
Q1 | $6.35M | Buy |
13,100
+5,500
| +72% | +$2.56M | 0.01% | 986 |
|
|
2024
Q4 | $3.06M | Buy |
7,600
+3,100
| +69% | +$1.44M | ﹤0.01% | 1256 |
|
|
2024
Q3 | $2.09M | Sell |
4,500
-900
| -17% | -$432K | ﹤0.01% | 1396 |
|
|
2024
Q2 | $2.53M | Sell |
5,400
-500
| -8% | -$217K | ﹤0.01% | 1230 |
|
|
2024
Q1 | $2.47M | Sell |
5,900
-14,700
| -71% | -$6.21M | ﹤0.01% | 1115 |
|
|
2023
Q4 | $8.38M | Sell |
20,600
-4,800
| -19% | -$1.77M | 0.01% | 738 |
|
|
2023
Q3 | $8.83M | Buy |
25,400
+12,000
| +90% | +$4.2M | 0.01% | 765 |
|
|
2023
Q2 | $4.72M | Buy |
13,400
+2,200
| +20% | +$741K | 0.01% | 890 |
|
|
2023
Q1 | $3.53M | Buy |
11,200
+5,200
| +87% | +$1.56M | 0.01% | 1118 |
|
|
2022
Q4 | $1.73M | Buy |
6,000
+3,000
| +100% | +$914K | ﹤0.01% | 1329 |
|
|
2022
Q3 | $869K | Buy |
3,000
+2,500
| +500% | +$719K | ﹤0.01% | 1435 |
|
|
2022
Q2 | $141K | Sell |
500
-1,800
| -78% | -$482K | ﹤0.01% | 2097 |
|
|
2022
Q1 | $600K | Sell |
2,300
-3,700
| -62% | -$878K | ﹤0.01% | 2054 |
|
|
2021
Q4 | $1.32M | Sell |
6,000
-1,200
| -17% | -$233K | ﹤0.01% | 1785 |
|
|
2021
Q3 | $1.31M | Buy |
7,200
+3,600
| +100% | +$703K | ﹤0.01% | 1814 |
|
|
2021
Q2 | $726K | Sell |
3,600
-600
| -14% | -$126K | ﹤0.01% | 1875 |
|
|
2021
Q1 | $903K | Buy |
+4,200
| New | +$923K | ﹤0.01% | 1684 |
|
|
2020
Q3 | – | Sell |
-24,700
| Closed | -$7.17M | – | 2418 |
|
|
2020
Q2 | $7.17M | Sell |
24,700
-10,200
| -29% | -$2.77M | 0.01% | 1035 |
|
|
2020
Q1 | $8.3M | Sell |
34,900
-18,800
| -35% | -$4.31M | 0.01% | 928 |
|
|
2019
Q4 | $11.8M | Buy |
53,700
+9,400
| +21% | +$1.9M | 0.01% | 1045 |
|
|
2019
Q3 | $7.5M | Sell |
44,300
-4,900
| -10% | -$867K | 0.01% | 1254 |
|
|
2019
Q2 | $9.02M | Buy |
49,200
+2,000
| +4% | +$350K | 0.01% | 1235 |
|
|
2019
Q1 | $8.68M | Sell |
47,200
-40,900
| -46% | -$7.55M | 0.01% | 1207 |
|
|
2018
Q4 | $14.6M | Sell |
88,100
-24,700
| -22% | -$4.28M | 0.02% | 903 |
|
|
2018
Q3 | $21.7M | Sell |
112,800
-18,300
| -14% | -$3.26M | 0.02% | 844 |
|
|
2018
Q2 | $22.3M | Buy |
131,100
+3,900
| +3% | +$605K | 0.02% | 822 |
|
|
2018
Q1 | $20.7M | Sell |
127,200
-218,800
| -63% | -$35.7M | 0.02% | 863 |
|
|
2017
Q4 | $51.9M | Buy |
346,000
+26,300
| +8% | +$3.89M | 0.04% | 520 |
|
|
2017
Q3 | $48.6M | Buy |
319,700
+64,500
| +25% | +$9.71M | 0.04% | 523 |
|
|
2017
Q2 | $32.9M | Buy |
255,200
+26,300
| +11% | +$3.17M | 0.03% | 716 |
|
|
2017
Q1 | $25M | Sell |
228,900
-136,600
| -37% | -$12M | 0.02% | 878 |
|
|
2016
Q4 | $26.9M | Buy |
365,500
+121,400
| +50% | +$9.88M | 0.02% | 847 |
|
|
2016
Q3 | $21.3M | Sell |
244,100
-13,700
| -5% | -$1.29M | 0.02% | 940 |
|
|
2016
Q2 | $22.2M | Buy |
257,800
+173,600
| +206% | +$15M | 0.02% | 841 |
|
|
2016
Q1 | $6.69M | Buy |
84,200
+21,300
| +34% | +$1.93M | 0.01% | 1325 |
|
|
2015
Q4 | $7.92M | Buy |
62,900
+24,800
| +65% | +$2.99M | 0.01% | 1159 |
|
|
2015
Q3 | $3.97M | Sell |
38,100
-15,600
| -29% | -$2M | ﹤0.01% | 1363 |
|
|
2015
Q2 | $6.63M | Buy |
53,700
+23,900
| +80% | +$3.01M | 0.01% | 1279 |
|
|
2015
Q1 | $3.52M | Buy |
29,800
+300
| +1% | +$35.9K | ﹤0.01% | 1347 |
|
|
2014
Q4 | $3.5M | Buy |
29,500
+21,200
| +255% | +$2.39M | ﹤0.01% | 1342 |
|
|
2014
Q3 | $932K | Buy |
+8,300
| New | +$790K | ﹤0.01% | 1684 |
|
Other funds holding VRTX
VCM
VPM
Allianz Asset Management's VRTX Position: Q1 2026 in Review
Allianz Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 5.3% in Q1 2026, selling an estimated $903K and leaving 34,339 shares worth $15.3M. The position accounts for 0.02% of the portfolio, ranked #705.
Allianz Asset Management first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $340M in Q3 2018. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Allianz Asset Management held 34,339 shares of Vertex Pharmaceuticals worth $15.3M as of Q1 2026.
- Allianz Asset Management sold 1,937 Vertex Pharmaceuticals shares in Q1 2026, an estimated $903K.
- Vertex Pharmaceuticals made up 0.02% of Allianz Asset Management's portfolio in Q1 2026, its #705 holding.
- Allianz Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Vertex Pharmaceuticals position peaked at $340M in Q3 2018.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.